This paper analyses the integrated circuit and pharmaceutical GVCs to determine the scope of technical upgrading and value capture achieved by Chinese and Indian contract R&D firms within these GVCs. There are three main findings. First, the two sectors differ significantly in terms of the...

A host of strategic government policies including a process patent regime led to the rise of Indian pharmaceutical firms with significant process development capabilities. With policies getting liberalized overtime and a product patent regime in place, now firms’ survival crucially depends on...

The rising prominence of emerging market multinationals has become a salient aspect of the global economy. Among these new emerging multinationals, the Indian Pharmaceutical Companies (IPCs) have drawn the attention of the academia for their catch-up internationalization strategies and rapid...

The purpose of this paper is to understand and explain the internationalization process of Indian pharmaceutical firms through a variety of entry mode theories. Eight competing theories of entry mode are applied to the case and compared for their relative efficacy in explaining the...